Integrated Dermatology Taps Physician Partner as Its First Medical Chief

BOCA RATON, FL – January 26, 2026 – By Sandra Patterson

In a move that underscores a significant trend in the rapidly consolidating healthcare landscape, Integrated Dermatology has appointed Dr. Jeffrey Fromowitz, a respected practitioner and longtime partner, as its first-ever Chief Medical Officer (CMO). The decision signals a strategic effort to embed clinical authority at the highest level of the organization as it navigates continued expansion in a competitive market.

Dr. Fromowitz will take on the C-suite responsibilities effective immediately while continuing to lead his busy practice, Dermatology of Boca. This dual role places him in a unique position, with one foot in the boardroom and the other firmly in the examination room, a structure the company believes is key to its physician-led philosophy.

Integrated Dermatology, which operates in more than 28 states, has grown significantly since its founding in 2004 through a model of practice acquisitions and partnerships. The creation of a CMO position marks a critical inflection point, formalizing a commitment to keeping medical expertise central to its corporate strategy and operational decision-making.

A New Guard: The Clinician-Executive

The appointment of a practicing physician to a top executive role is a deliberate choice. As CMO, Dr. Fromowitz is tasked with a complex balancing act: championing clinical excellence and physician autonomy while helping to steer the strategic growth of a large, multi-state enterprise. His mandate includes maintaining high standards of patient care, implementing clinical best practices, and fostering a culture that attracts and retains top dermatological talent.

"Dr. Fromowitz has been a trusted partner for nearly 20 years, giving him a deep understanding of our brand, our values, and how our physician partnership model works,” said Nicholas Anguish, President of Integrated Dermatology, in the company's announcement. “His experience and leadership make him the perfect choice to ensure the physician voice remains at the center of every decision.”

Dr. Fromowitz’s credentials lend significant weight to his new role. He is a Diplomate of the American Board of Dermatology and holds a board certification in the highly specialized field of Micrographic Dermatologic Surgery (Mohs Surgery) for treating skin cancer. His fellowships include the American Academy of Dermatology and the American Society for Mohs Micrographic Surgery, among others. This extensive background provides him with the clinical credibility needed to lead a large network of his peers.

“I’m honored to step into this role and further support the physicians and practices that make Integrated Dermatology unique,” Dr. Fromowitz stated. “Having experienced the partnership model firsthand, I’ve seen how Integrated empowers physicians while preserving medical autonomy, and I look forward to working closely with the leadership team to elevate clinical excellence.”

The Strategic Imperative of Clinical Leadership

The creation of a CMO role at Integrated Dermatology is not happening in a vacuum. It reflects a broader industry trend where large physician groups, often backed by private equity, are formalizing clinical governance to manage their expanding networks. As practices are acquired and integrated, a CMO serves as a crucial bridge between corporate management and frontline clinicians, tasked with standardizing quality without stifling the art of medicine.

The U.S. dermatology market, while growing, is also described by market analysts as highly fragmented. In recent years, it has become a hotbed of consolidation. While Integrated Dermatology describes itself as the country’s largest independent dermatology provider, it competes in a space with other major players like Forefront Dermatology and U.S. Dermatology Partners, which are also rapidly expanding their footprints. In this environment, demonstrating a commitment to quality and a physician-centric culture becomes a key differentiator.

The CMO role is seen as essential for ensuring that as the organization scales, its clinical foundation remains solid. This involves more than just oversight; it includes developing quality improvement initiatives, managing patient safety protocols, and ensuring that new technologies and treatments are vetted and implemented responsibly across all partner practices.

Redefining Independence in a Consolidated Market

Integrated Dermatology’s growth is built on a "physician partnership model," a structure becoming increasingly common in specialty medicine. This model promises physicians the best of both worlds: relief from the administrative burdens of running a practice—such as billing, human resources, and payroll—while retaining clinical autonomy.

For many small practice owners, the appeal is undeniable. Partnering with a larger entity provides access to capital for new equipment, expanded facilities, and sophisticated marketing, along with the negotiating power of a large group when dealing with insurers and suppliers. It also offers a viable succession plan for physicians nearing retirement.

However, this model is not without its critics. Across healthcare, the rise of corporate-backed practice groups has raised concerns about the potential for profit motives to overshadow patient care. Observers worry that pressure to increase patient volume or favor more lucrative procedures could compromise clinical judgment. The term "independent" itself becomes nuanced when practices operate under a corporate umbrella with its own financial stakeholders and growth targets.

The appointment of a CMO like Dr. Fromowitz can be interpreted as a direct response to these concerns. By placing a tenured, respected physician in a position of power, the company aims to reassure both its partner doctors and their patients that clinical considerations will continue to guide the organization. The success of this model will ultimately depend on whether the CMO can effectively advocate for medical priorities within a corporate structure, ensuring that the quest for sustainable growth does not come at the expense of quality care.